Jazz Pharmaceuticals Cash Flow Statement (2010-2025) | JAZZ

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	117.67M	-364.66M	-49.58M	-32.35M	5.83M	37.11M	-17.13M	-239.99M	70.40M	106.11M	146.69M	94.60M	-13.30M	168.58M	215.31M	191.10M		-718.38M	251.46M	203.47M
Depreciation and Depletion (Quarter)	4.78M	6.83M	7.77M	7.33M	7.62M	7.75M	7.59M	7.34M	7.57M	7.51M	7.67M	7.65M	7.65M	7.81M	7.78M	9.51M	10.43M	11.91M	9.88M	9.43M
Share-based Compensation (Quarter)	34.48M	48.16M	53.24M	53.12M	50.07M	53.69M	56.68M	61.56M	56.35M	61.43M	56.12M	52.94M	61.44M	56.65M	59.76M	70.19M	67.65M	64.50M	88.12M	70.85M
Deferred Taxes (Quarter)	-19.11M	190.70M	-74.99M	-27.39M	-45.34M	-36.98M	-64.56M	-145.38M	-66.06M	-79.33M	-78.92M	-35.90M	-66.39M	-75.18M	-64.40M	-2.35M	-43.83M	-66.42M	-271.41M	-63.31M
Gains from Investment Securities (Quarter)	23.78M	-23.61M	29.43M	-39.63M	-0.98M	30.07M	-2.74M	-2.31M	43.27M	-30.36M	-67.17M	232.14M	49.30M	-64.82M	25.06M	48.21M	0.75M	-7.79M	-10.98M	93.24M
Asset Writedowns and Impairment (Quarter)							133.65M					61.01M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	285.00M	41.70M	274.06M	177.75M	208.98M	303.04M	417.99M	341.97M	320.71M	296.76M	307.19M	167.34M	267.23M	331.35M	398.75M	398.58M	429.78M	88.86M	474.62M	362.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	68.19M	140.48M	159.80M	157.29M	172.09M	148.46M	141.23M	137.39M	149.79M	152.06M	154.88M	151.55M	155.73M	155.22M	157.46M	158.90M	154.45M	162.10M	168.37M	169.74M
Amortization of Deferred Charges (Quarter)	15.69M
Depreciation & Amortization (CF) (Quarter)	4.78M	6.83M	7.77M	7.33M	7.62M	7.75M	7.59M	7.34M	7.57M	7.51M	7.67M	7.65M	7.65M	7.81M	7.78M	9.51M	10.43M	11.91M	9.88M	9.43M
Change in Working Capital
Change in Receivables (Quarter)	18.25M	16.59M	-6.88M	64.78M	9.72M	24.51M	9.64M	46.27M	-28.46M	-13.98M	18.86M	75.46M	8.44M	-8.72M	22.26M	-0.86M	-66.05M	55.52M	51.00M	65.81M
Change in Inventory (Quarter)	22.01M	7.39M	4.49M	14.97M	24.81M	17.12M	8.53M	-0.82M	6.27M	0.82M	4.93M	1.40M	12.84M	4.75M	9.29M	18.66M	35.62M	26.23M	31.91M	-7.72M
Change in Account Payables (Quarter)	51.29M	-31.98M	-0.14M	37.85M	-27.62M	2.85M	28.96M	-15.41M	34.29M	-26.82M	10.24M	-8.10M	-19.60M	15.45M	-12.79M	-3.13M	19.13M	-12.67M	62.36M	-28.97M
Change in Accured Expenses (Quarter)	13.72M	42.97M	36.85M	48.82M	-23.24M	-21.19M	62.29M	148.13M	-96.98M	7.18M	13.55M	53.02M	34.68M	-29.27M	51.02M	-95.70M	181.04M	-256.39M	126.28M	-22.91M
Change in Taxes (Quarter)	24.62M	-46.46M	31.01M	-24.70M	16.77M	-21.23M	4.30M	-1.52M	25.41M	20.52M	15.22M	-35.94M	14.86M	3.17M	2.07M	-34.84M	12.99M	46.28M	12.74M	-34.78M
Other Working Capital Changes (Quarter)	4.77M	16.58M	-22.96M	84.93M	-23.17M	0.52M	21.08M	-9.83M	1.83M	17.46M	-19.76M	127.57M	-3.83M	1.99M	1.13M	22.84M	-36.28M	28.07M	6.67M	-27.49M
Investing Activities
Capital Expenditures (Quarter)	2.17M	7.18M	8.33M	9.97M	12.29M	12.28M	-4.90M	9.38M	3.82M	5.74M	4.30M	-13.86M	6.90M	7.09M	10.79M	-24.78M	13.88M	844.17M	-816.03M	816.03M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)			17.89M		25.00M												25.00M		30.00M	53.50M
Acquisitions (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)	760.00M	335.00M						60.00M			20.00M	250.00M	120.00M	80.00M	355.00M	290.00M	310.00M	470.00M	400.00M	180.00M
Cash from Investing Activities (Quarter)	737.13M	-5912.37M	-26.81M	-10.09M	-37.29M	-89.16M	4.60M	-324.38M	-4.82M	-85.74M	-174.30M	101.80M	-271.90M	-257.09M	214.09M	-193.29M	-168.93M	-641.02M	-327.80M	-372.16M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	18.28M	4,664.04M	-465.18M	-246.61M	-270.81M	10.78M	-289.05M	19.60M	-29.79M	-96.67M	-78.49M	-100.31M	-56.55M	-161.09M	246.43M	-8.28M	-813.47M	-124.53M	-10.83M	75.44M
Additional items
Exchange Rate Effect (Quarter)	-0.64M	0.51M	-1.69M	-1.39M	-1.49M	-4.22M	-5.45M	4.93M	0.33M	0.03M	-1.02M	1.79M	-1.70M	-0.76M	3.07M	-2.29M	1.70M	4.62M	0.20M	0.03M
Change in Cash (Quarter)	1,039.76M	-1206.13M	-219.62M	-80.33M	-100.61M	220.43M	128.09M	42.12M	286.43M	114.39M	53.39M	170.62M	-62.92M	-87.58M	862.33M	194.73M	-550.92M	-672.07M	136.19M	65.83M
Free Cash Flow (Quarter)	282.83M	34.52M	265.73M	167.79M	196.69M	290.76M	422.89M	332.59M	316.89M	291.03M	302.90M	181.20M	260.32M	324.26M	387.96M	423.36M	415.90M	-755.32M	1,290.65M	-453.51M
Net Cash Flow (Quarter)	1,040.40M	-1206.64M	-217.93M	-78.95M	-99.12M	224.65M	133.54M	37.19M	286.10M	114.36M	54.40M	168.83M	-61.23M	-86.82M	859.26M	197.02M	-552.61M	-676.69M	135.99M	65.80M

Research Tools

Jazz Pharmaceuticals Cash Flow Statement (2010-2025) | JAZZ

Create an account

Sign In

Reset Password